Clinical Characteristics and Prognostic Prediction of Secondary Solid Malignancies in Patients With Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
Lymphoma patients who develop secondary cancers show different survival patterns depending on lymphoma subtype, and a prediction tool can help doctors assess prognosis after a second cancer appears.
In a Chinese single-center cohort of 1,866 lymphoma patients, secondary solid malignancies occurred more frequently in FL than DLBCL, with thyroid cancer predominating; DLBCL patients with SPSMs had inferior OS particularly in non-GCB subtypes. A nomogram incorporating lymphoma-related factors achieved AUC 0.761 for OS prediction after SPSM diagnosis.
What the study was
- Study design
- Retrospective observational, single-center cohort
- Population
- DLBCL (n=1,377) and FL (n=489) patients; 81 with secondary solid malignancies
- Sample size
- 1866
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- Cancer Medicine
Why it surfaced
Single-center Chinese cohort with small SPSM subgroup (n=81); adds subtype-specific data on SPSMs but limited generalizability; nomogram requires multi-center validation.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.